drug protocol number

1160.129

drug sponsor

Boehringer Ingelheim

drug study

Dabigatran (dabigatran etexilate = prodrug)

drug trial site

King Fahad Medical City (Riyadh), King Faisal Hospital (Taif) , King Salman Bin AbdulAziz Hospital (Riyadh), King Fahad Hospital (Hofuf), Armed Forces Hospital (Southern Region) , Armed Forces Hospital (North West Region)

drug status

Ongoing

drug phase